Your browser doesn't support javascript.
loading
Correction: Exploring the Effects of Ixekizumab on Pain in Patients with Ankylosing Spondylitis Based on Objective Measures of Inflammation: Post Hoc Analysis from a Large Randomized Clinical Trial.
de Vlam, Kurt; Maksymowych, Walter P; Gallo, Gaia; Rahman, Proton; Mease, Philip; Krishnan, Venkatesh; McVeigh, Conor J; Lisse, Jeffrey; Zhu, Danting; Bolce, Rebecca J; Conaghan, Philip G.
Affiliation
  • de Vlam K; University Hospital Leuven, Leuven, Belgium. kurt.devlam@uzleuven.be.
  • Maksymowych WP; Department of Medicine, Division of Rheumatology at the University of Alberta, Edmonton, Alberta, Canada.
  • Gallo G; Eli Lilly and Company, Indianapolis, USA.
  • Rahman P; Department of Medicine, Memorial University, St. John's, Newfoundland, A1C 5B8, Canada.
  • Mease P; Swedish Medical Center/Providence St, Joseph Health and University of Washington, Seattle, Washington, USA.
  • Krishnan V; Eli Lilly and Company, Indianapolis, USA.
  • McVeigh CJ; Eli Lilly and Company, Indianapolis, USA.
  • Lisse J; Eli Lilly and Company, Indianapolis, USA.
  • Zhu D; Eli Lilly and Company, Indianapolis, USA.
  • Bolce RJ; Eli Lilly and Company, Indianapolis, USA.
  • Conaghan PG; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre, Leeds, UK.
Rheumatol Ther ; 11(4): 1063, 2024 Aug.
Article in En | MEDLINE | ID: mdl-38874859

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Rheumatol Ther Year: 2024 Document type: Article Affiliation country: Bélgica

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Rheumatol Ther Year: 2024 Document type: Article Affiliation country: Bélgica